Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block in Total Hip Arthroplasty
NCT04729686Phase 4Recruiting
- Sponsor
- LifeBridge Health
- Start
- Dec 2020
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 4, randomised trial in hip osteoarthritis and hip arthropathy (2 arms), sponsored by LifeBridge Health. Primary endpoints: Visual Analog Pain Scale Score and Postoperative Opioid Consumption. Started Dec 2020; status: recruiting.
02
Conditions
hip osteoarthritiship arthropathy
Beyond the preview
Go deeper on NCT04729686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04729686.